These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 9125775)
1. Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver. Lalwani ND; Dethloff LA; Haskins JR; Robertson DG; de la Iglesia FA Toxicol Pathol; 1997; 25(2):165-76. PubMed ID: 9125775 [TBL] [Abstract][Full Text] [Related]
2. The peroxisome proliferations WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats. Miller RT; Shah RS; Cattley RC; Popp JA Toxicol Appl Pharmacol; 1996 Jun; 138(2):317-23. PubMed ID: 8658533 [TBL] [Abstract][Full Text] [Related]
3. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS; Cattley RC; Conway JG; Popp JA Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084 [TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents. Eldrige SR; Butterworth BE; Goldsworthy TL Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster. Lake BG; Evans JG; Cunninghame ME; Price RJ Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414 [TBL] [Abstract][Full Text] [Related]
6. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643. Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444 [TBL] [Abstract][Full Text] [Related]
7. NTP Hepatotoxicity Studies of the Liver Carcinogen Methapyrilene Hydrochloride (CAS No. 135-23-9) Administered in Feed to Male F344/N Rats. Toxic Rep Ser; 2000 Feb; 46():1-C7. PubMed ID: 11986676 [TBL] [Abstract][Full Text] [Related]
8. Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump. Eldridge SR; Tilbury LF; Goldsworthy TL; Butterworth BE Carcinogenesis; 1990 Dec; 11(12):2245-51. PubMed ID: 2265476 [TBL] [Abstract][Full Text] [Related]
9. The hepatocarcinogen methapyrilene but not the analog pyrilamine induces sustained hepatocellular replication and protein alterations in F344 rats in a 13-week feed study. Cunningham ML; Pippin LL; Anderson NL; Wenk ML Toxicol Appl Pharmacol; 1995 Apr; 131(2):216-23. PubMed ID: 7716764 [TBL] [Abstract][Full Text] [Related]
10. Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication. Wada N; Marsman DS; Popp JA Fundam Appl Toxicol; 1992 Jan; 18(1):149-54. PubMed ID: 1601204 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Biegel LB; Hurtt ME; Frame SR; O'Connor JC; Cook JC Toxicol Sci; 2001 Mar; 60(1):44-55. PubMed ID: 11222872 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643. Obourn JD; Frame SR; Bell RH; Longnecker DS; Elliott GS; Cook JC Toxicol Appl Pharmacol; 1997 Aug; 145(2):425-36. PubMed ID: 9266817 [TBL] [Abstract][Full Text] [Related]
13. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Peters JM; Cattley RC; Gonzalez FJ Carcinogenesis; 1997 Nov; 18(11):2029-33. PubMed ID: 9395198 [TBL] [Abstract][Full Text] [Related]
14. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Eacho PI; Lanier TL; Brodhecker CA Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515 [TBL] [Abstract][Full Text] [Related]
15. Detection and quantification of ploidy, nuclearity, and DNA synthesis in rat hepatocytes after administration of a peroxisome proliferator. Styles JA Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):225-7. PubMed ID: 8013411 [TBL] [Abstract][Full Text] [Related]
17. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Marsman DS; Goldsworthy TL; Popp JA Carcinogenesis; 1992 Jun; 13(6):1011-7. PubMed ID: 1600604 [TBL] [Abstract][Full Text] [Related]
18. Induction of sister chromatid exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator, Wy-14,643. Hwang JJ; Hsia MT; Jirtle RL Mutat Res; 1993 Apr; 286(2):123-33. PubMed ID: 7681523 [TBL] [Abstract][Full Text] [Related]
19. Toxicity studies of WY-14,643 (CAS No. 50892-23-4) administered in feed to male Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters. Cunningham ML Toxic Rep Ser; 2007 Oct; (62):1-136. PubMed ID: 24743700 [TBL] [Abstract][Full Text] [Related]
20. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver. Cattley RC; Marsman DS; Popp JA Carcinogenesis; 1991 Mar; 12(3):469-73. PubMed ID: 1849052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]